About US
Contact us
>>Back
Similar partnerships have proven beneficial in the past, such as when Amgen helped drug testers develop a detection method for Aranesp, leading to three athletes at the 2002 Winter Olympic Games being caught.
GlaxoSmithKline Joins Fight Against Doping in Sport
- Publisher：
- Publication：2011/7/6
UK-based pharmaceutical major GlaxoSmithKline has signed a long-term agreement with the World Anti-Doping Agency to help detect emerging performance-enhance drugs in sport.
Under the agreement, the agency will have access to products that could be used as performance-enhancing drugs in the early stages of their development, allowing it to pre-emptively develop tests to detect them.
Scientists will analyse new drugs for stimulatory or performance enhancing effects and flag them, with data being delivered to the World Anti-Doping Agency.